Duff & Phelps Investment Management CO Biogen Inc. Transaction History

Duff & Phelps Investment Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $306,350 - $385,985	-1,581 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $13,866 - $18,083	-49 Reduced 3.01%	1,581 $447,000
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $31,080 - $49,765	-120 Reduced 6.86%	1,630 $564,000
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $27,939 - $32,732	-115 Reduced 6.17%	1,750 $490,000
Q4 2020 Jan 29, 2021	SELL	$236.26 - $355.63 $70,878 - $106,689	-300 Reduced 13.86%	1,865 $457,000
Q3 2018 Oct 22, 2018	SELL	$293.51 - $383.83 $29,351 - $38,383	-100 Reduced 4.42%	2,165 $765,000
Q2 2018 Aug 02, 2018	SELL	$257.52 - $306.91 $25,752 - $30,691	-100 Reduced 4.23%	2,265 $657,000
Q3 2017 Oct 25, 2017	BUY	$281.15 - $329.69 $664,919 - $779,716	2,365	2,365 $741,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Duff & Phelps Investment Management CO with notifications on news.